Fewer Self-Injury Events With Lithium for Bipolar Disorder

This article originally appeared here.
Share this content:
Fewer Self-Injury Events With Lithium for Bipolar Disorder
Fewer Self-Injury Events With Lithium for Bipolar Disorder

FRIDAY, May 13, 2016 (HealthDay News) -- Patients with bipolar disorder taking lithium have lower rates of self-harm and unintentional injury compared to those taking other mood stabilizers, according to research published online May 11 in JAMA Psychiatry.

Joseph Hayes, M.B., Ch.B., fellow of psychiatry at University College London, and colleagues collected medical data on 6,671 patients diagnosed with bipolar disorder and prescribed only one of the following drugs: lithium, valproate, olanzapine, or quetiapine.

The investigators found that patients on lithium were less likely to harm themselves, either intentionally or by accident. Patients taking one of the alternative mood stabilizers were 40 percent more likely to harm themselves compared to patients on lithium. Patients on valproate or quetiapine were 32 to 34 percent more likely to experience unintentional injury, most likely while experiencing a manic episode. The suicide rate was lower in the lithium group, but too few suicides occurred to allow accurate risk estimates.

"This is important because people with bipolar disorder are 15 times more likely to die by suicide and six times more likely to die by accidental injury than the general population," Hayes told HealthDay.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »